United StatesGlucagon Emergency Kit for Low Blood Sugar (Glucagon for Injection USP, 1 mg per vial, with diluent and 1 mL syringe), NDC 70748-311-01, in lots WB00010 (exp Jan 2027), WB00017 and WB00019 (exp Feb 2027), WB00070 (exp Jun 2027), WB00077 and WB00078 (exp Jul 2027), and WB00130 (exp Nov 2027). Lupin Pharmaceuticals recalled these kits after a CGMP deviation produced an out-of-specification result for the gliding force functionality test during 12‑month long-term stability testing; 64,894 units were distributed nationwide in the U.S.
What's being recalled
Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01
Recalling firm: Lupin Pharmaceuticals Inc., Naples, FL, United States.
How to identify it
Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027.
The hazard
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide within the U.S.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)